Pharmacist-led education for managing allergic rhinitis
The Effectiveness of Pharmacist-led Educational Model in Patients With Allergic Rhinitis in a Malaysian Tertiary Hospital: A Randomised Control Trial Protocol (AR-PRISE RCT)
This study is testing if getting education from a pharmacist can help people with allergic rhinitis manage their symptoms better than just standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 154 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Universiti Sains Malaysia Academic / other |
| Locations | 1 site (Ipoh, Perak) |
| Trial ID | NCT06027736 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of a pharmacist-led educational model, known as the AR-PRISE Model, in managing patients with allergic rhinitis compared to standard pharmaceutical care. Conducted over six months at a tertiary hospital's otorhinolaryngology outpatient clinic, participants will be randomized into two groups: one receiving standard care and the other receiving pharmacist-led education. The study will assess various outcomes, including disease severity, knowledge level, symptom control, medication adherence, and quality of life at baseline and after six months. Follow-ups will occur at specified intervals to monitor progress and outcomes.
Who should consider this trial
Good fit: Ideal candidates are Malaysian adults aged 18 to 80 diagnosed with allergic rhinitis who can read and write in English or Malay.
Not a fit: Patients who are pregnant, lactating, or have chronic rhinosinusitis or other significant comorbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the management and quality of life for patients suffering from allergic rhinitis.
How similar studies have performed: While pharmacist-led educational interventions have shown promise in other areas of healthcare, this specific approach for allergic rhinitis is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inclusion criteria for patients include an aged 18 to 80, Malaysian, diagnosed with allergic rhinitis, and capable of reading and writing in English or Malay, who attend the otorhinolaryngology outpatient clinic at Raja Permaisuri Bainun Hospital. Exclusion Criteria: * Patients who are pregnant, lactating, or have a comorbid diagnosis of chronic rhinosinusitis will be excluded. * Patients having psychiatric problems, dementia, terminal illnesses, comorbidities, post-COVID-19 conditions with symptoms that continue beyond 3 months after being infected will be excluded.
Where this trial is running
Ipoh, Perak
- Raja Permaisuri Bainun Hospital — Ipoh, Perak, Malaysia (Recruiting)
Study contacts
- Study coordinator: Chii-chii Chew
- Email: chiichii.crcperak@gmail.com
- Phone: +605 208 5148
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.